Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1493276

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1493276

Esoteric Testing Market Size, Share & Trends Analysis Report By Type (Oncology Testing, Infectious Disease Testing), By Technology (Chemiluminescence Immunoassay), By End-use, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Esoteric Testing Market Growth & Trends:

The global esoteric testing market size is anticipated to reach USD 47.98 billion by 2030, expanding at a CAGR of 11.81% from 2024 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth include rising prevalence of cancer and growing need for safe and effective tests. The International Agency for Research on Cancer reports that 19,292,789 cancer cases were recorded in 2020 and estimates that number will rise to 50,550,287 by 2025. The most frequently reported cancers are breast, colorectal, lung, prostate, and stomach.

Moreover, the rising prevalence of chronic and infectious diseases aided by the advancements in esoteric DNA sequencing technologies is further anticipated to drive overall growth of the market. For instance, according to CDC, heart disease are leading cause of death in the U.S., and accounts for the death of one person every 33 seconds. Furthermore, according to the National Diabetes Statistics Report, 11.6% of the total population in the U.S. suffer from diabetes. Such a high prevalence of major infectious diseases is anticipated to drive the demand for esoteric testing.

The growing preference for esoteric testing, attributed to advantages like high efficacy and specificity, high signal intensity, good precision, and high accuracy, is projected to drive the demand for advanced tests during the forecast period. Furthermore, rising awareness of esoteric testing devices among physicians and patients for early disease diagnosis. This shift is anticipated to substantially boost the adoption of tests, thereby driving market growth.

Moreover, the rising healthcare expenditure aided with rising preference and awareness regarding preventive healthcare is fueling the growth of the market. For example, the Affordable Care Act (ACA) helps in providing accessible and affordable for people in U.S. by providing insurance plans for recommended preventive services. Additionally, the growing patient participation in disease management and the shift towards evidence-based treatment are also contributing to the growth of the market.

Similarly, these tests are a simple way to identify rare diseases. Therefore, the population's increasing incidence of rare diseases is anticipated to support market expansion. As per the U.S. Department of Health and Human Services, around 2,205 new West Nile virus disease cases in the U.S. The esoteric testing market is growing because esoteric tests for infectious diseases can easily detect these rare diseases. Government-sponsored initiatives, including awareness campaigns, screening programs, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, India's Health Minister Cancer Patient Fund (HMCPF) program financially assists deprived cancer patients. This is anticipated to increase demand for esoteric testing and promote regional growth.

Key players operating in the market are constantly focusing on development of novel products to meet the rising demand for preventive and early diseases diagnosis. For instance, in July 2023, Quest Diagnostics announced the launch of consumer-initiated genetic tests with unique feature including robust NGS support services, ordering, and access to one-on-one genetic testing. Moreover, major players are focusing on geographic expansion to enhance their presence and expand access to effective products. For instance, in June 2022, SRL Diagnostics opened a reference laboratory in Ashok Nagar, Chennai, India. The 20,000-square-foot laboratory can perform over one lakh monthly tests, ranging from widespread examinations to unidentified and genetic tests.

Esoteric Testing Market Report Highlights:

  • Based on type, the oncology segment dominated the market in 2023 owing to prominent application of esoteric testing in cancer diagnosis and genetic testing segment is expected to grow at the fastest CAGR over the forecast period
  • Based on technology, the chemiluminescence immunoassay technology segment dominated the market in 2023. However, enzyme-linked immunosorbent assay is anticipated to witness fastest growth over the forecast period
  • Based on end-use, the independent and reference laboratories segment held the largest share in 2023. However, hospital-based laboratories is anticipated to witness fastest growth over the forecast period
  • North America dominated the market owing to factors such as rising incidence of infectious diseases, government support for quality healthcare, high purchasing power, and efficient reimbursement scenario
Show more
Product Code: GVR-4-68040-272-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Esoteric Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of infectious disease
      • 3.2.1.2. Technological advancements in esoteric testing
      • 3.2.1.3. Increasing per capita income
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of skilled healthcare professional in developing countries
      • 3.2.2.2. Stringent regulatory framework
  • 3.3. Esoteric Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Esoteric Testing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Esoteric Testing Market Movement Analysis
  • 4.3. Global Esoteric Testing Market by Type Outlook
  • 4.4. Oncology testing
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Infectious disease testing
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Genetic testing
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Endocrinology testing
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Toxicology testing
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Neurology testing
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Esoteric Testing Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Esoteric Testing Market Movement Analysis
  • 5.3. Global Esoteric Testing Market by Technology Outlook
  • 5.4. Chemiluminescence immunoassay
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Enzyme-linked immunosorbent assay
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Mass spectrometry
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Real time polymerase chain reaction
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Flow cytometry
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Esoteric Testing Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Esoteric Testing Market Movement Analysis
  • 6.3. Global Esoteric Testing Market by End-use Outlook
  • 6.4. Hospital-based laboratories
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.5. Independent and reference laboratories
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Esoteric Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Laboratory Corporation of America Holdings
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. OPKO Health, Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Quest Diagnostics Incorporated
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Sonic Healthcare Limited
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. H.U. Group Holdings, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Kindstar Globalgene Technology, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Stanford Health Care
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Mayo Foundation for Medical Education and Research
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. ARUP Laboratories.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Athena Esoterix
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. ACM Global Laboratories
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
      • 8.3.14.3. Product benchmarking
    • 8.3.14. Healius Limited.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-272-6

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Europe esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Germany esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 23 France esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 44 China esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 China esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 51 India esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 South Korea esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 54 South Korea esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Korea esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 57 Australia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Thailand esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 Thailand esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Thailand esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 64 Latin America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Brazil esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Esoteric Testing market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 75 MEA esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 77 MEA esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 78 MEA esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait esoteric testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Esoteric testing market: market outlook
  • Fig. 14 Esoteric testing competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Esoteric testing market driver impact
  • Fig. 20 Esoteric testing market restraint impact
  • Fig. 21 Esoteric testing market strategic initiatives analysis
  • Fig. 22 Esoteric testing market: Type movement analysis
  • Fig. 23 Esoteric testing market: Type outlook and key takeaways
  • Fig. 24 Oncology testing market estimates and forecast, 2018 - 2030
  • Fig. 25 Infectious disease testing estimates and forecast, 2018 - 2030
  • Fig. 26 Genetic testing market estimates and forecast, 2018 - 2030
  • Fig. 27 Endocrinology testing estimates and forecast, 2018 - 2030
  • Fig. 28 Toxicology testing market estimates and forecast, 2018 - 2030
  • Fig. 29 Neurology testing market estimates and forecast, 2018 - 2030
  • Fig. 30 Others estimates and forecast, 2018 - 2030
  • Fig. 31 Esoteric testing Market: Technology movement Analysis
  • Fig. 32 Esoteric testing market: Technology outlook and key takeaways
  • Fig. 33 Chemiluminescence immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 34 Mass spectrometry market estimates and forecasts, 2018 - 2030
  • Fig. 35 Enzyme-linked immunosorbent assay market estimates and forecasts, 2018 - 2030
  • Fig. 36 Real time polymerase chain reaction market estimates and forecasts, 2018 - 2030
  • Fig. 37 Flow cytometry market estimates and forecasts, 2018 - 2030
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030
  • Fig. 39 Esoteric testing market: End use movement analysis
  • Fig. 40 Esoteric testing market: End use outlook and key takeaways
  • Fig. 41 Hospital-based laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 42 Independent and reference laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030
  • Fig. 44 Global esoteric testing market: Regional movement analysis
  • Fig. 45 Global esoteric testing market: Regional outlook and key takeaways
  • Fig. 46 Global esoteric testing market share and leading players
  • Fig. 47 North America market share and leading players
  • Fig. 48 Europe market share and leading players
  • Fig. 49 Asia Pacific market share and leading players
  • Fig. 50 Latin America market share and leading players
  • Fig. 51 Middle East & Africa market share and leading players
  • Fig. 52 North America: SWOT
  • Fig. 53 Europe SWOT
  • Fig. 54 Asia Pacific SWOT
  • Fig. 55 Latin America SWOT
  • Fig. 56 MEA SWOT
  • Fig. 57 North America, by country
  • Fig. 58 North America
  • Fig. 59 North America market estimates and forecasts, 2018 - 2030
  • Fig. 60 U.S. Key Country Dynamics
  • Fig. 61 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 62 Canada Key Country Dynamics
  • Fig. 63 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 64 Europe
  • Fig. 65 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 66 UK Key Country Dynamics
  • Fig. 67 UK market estimates and forecasts, 2018 - 2030
  • Fig. 68 Germany Key Country Dynamics
  • Fig. 69 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 70 France Key Country Dynamics
  • Fig. 71 France market estimates and forecasts, 2018 - 2030
  • Fig. 72 Italy Key Country Dynamics
  • Fig. 73 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 74 Spain Key Country Dynamics
  • Fig. 75 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 76 Denmark Key Country Dynamics
  • Fig. 77 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 78 Sweden Key Country Dynamics
  • Fig. 79 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 80 Norway Key Country Dynamics
  • Fig. 81 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 82 Asia Pacific
  • Fig. 83 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 84 China Key Country Dynamics
  • Fig. 85 China market estimates and forecasts, 2018 - 2030
  • Fig. 86 Japan Key Country Dynamics
  • Fig. 87 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 88 India Key Country Dynamics
  • Fig. 89 India market estimates and forecasts, 2018 - 2030
  • Fig. 90 Thailand Key Country Dynamics
  • Fig. 91 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 92 South Korea Key Country Dynamics
  • Fig. 93 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 94 Australia Key Country Dynamics
  • Fig. 95 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 96 Latin America
  • Fig. 97 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 98 Brazil Key Country Dynamics
  • Fig. 99 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 100 Mexico Key Country Dynamics
  • Fig. 101 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 102 Argentina Key Country Dynamics
  • Fig. 103 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 104 Middle East and Africa
  • Fig. 105 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 106 South Africa Key Country Dynamics
  • Fig. 107 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 108 Saudi Arabia Key Country Dynamics
  • Fig. 109 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 110 UAE Key Country Dynamics
  • Fig. 111 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 112 Kuwait Key Country Dynamics
  • Fig. 113 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 114 Market share of key market players- esoteric testing market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!